Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

14,860 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Changes in the influence of lymphoma- and HIV-specific factors on outcomes in AIDS-related non-Hodgkin lymphoma.
Barta SK, Samuel MS, Xue X, Wang D, Lee JY, Mounier N, Ribera JM, Spina M, Tirelli U, Weiss R, Galicier L, Boue F, Little RF, Dunleavy K, Wilson WH, Wyen C, Remick SC, Kaplan LD, Ratner L, Noy A, Sparano JA. Barta SK, et al. Among authors: lee jy. Ann Oncol. 2015 May;26(5):958-966. doi: 10.1093/annonc/mdv036. Epub 2015 Jan 28. Ann Oncol. 2015. PMID: 25632071 Free PMC article. Review.
Chemotherapy for human immunodeficiency virus-associated non-Hodgkin's lymphoma in combination with highly active antiretroviral therapy.
Ratner L, Lee J, Tang S, Redden D, Hamzeh F, Herndier B, Scadden D, Kaplan L, Ambinder R, Levine A, Harrington W, Grochow L, Flexner C, Tan B, Straus D; AIDS Malignancy Consortium. Ratner L, et al. J Clin Oncol. 2001 Apr 15;19(8):2171-8. doi: 10.1200/JCO.2001.19.8.2171. J Clin Oncol. 2001. PMID: 11304769 Clinical Trial.
Angiogenesis inhibitor IM862 is ineffective against AIDS-Kaposi's sarcoma in a phase III trial, but demonstrates sustained, potent effect of highly active antiretroviral therapy: from the AIDS Malignancy Consortium and IM862 Study Team.
Noy A, Scadden DT, Lee J, Dezube BJ, Aboulafia D, Tulpule A, Walmsley S, Gill P. Noy A, et al. J Clin Oncol. 2005 Feb 10;23(5):990-8. doi: 10.1200/JCO.2005.11.043. Epub 2004 Dec 14. J Clin Oncol. 2005. PMID: 15598977 Clinical Trial.
Rituximab does not improve clinical outcome in a randomized phase 3 trial of CHOP with or without rituximab in patients with HIV-associated non-Hodgkin lymphoma: AIDS-Malignancies Consortium Trial 010.
Kaplan LD, Lee JY, Ambinder RF, Sparano JA, Cesarman E, Chadburn A, Levine AM, Scadden DT. Kaplan LD, et al. Among authors: lee jy. Blood. 2005 Sep 1;106(5):1538-43. doi: 10.1182/blood-2005-04-1437. Epub 2005 May 24. Blood. 2005. PMID: 15914552 Free PMC article. Clinical Trial.
Dose-reduced busulfan, cyclophosphamide, and autologous stem cell transplantation for human immunodeficiency virus-associated lymphoma: AIDS Malignancy Consortium study 020.
Spitzer TR, Ambinder RF, Lee JY, Kaplan LD, Wachsman W, Straus DJ, Aboulafia DM, Scadden DT. Spitzer TR, et al. Among authors: lee jy. Biol Blood Marrow Transplant. 2008 Jan;14(1):59-66. doi: 10.1016/j.bbmt.2007.03.014. Biol Blood Marrow Transplant. 2008. PMID: 18158962 Free PMC article. Clinical Trial.
Immunophenotypic analysis of AIDS-related diffuse large B-cell lymphoma and clinical implications in patients from AIDS Malignancies Consortium clinical trials 010 and 034.
Chadburn A, Chiu A, Lee JY, Chen X, Hyjek E, Banham AH, Noy A, Kaplan LD, Sparano JA, Bhatia K, Cesarman E. Chadburn A, et al. Among authors: lee jy. J Clin Oncol. 2009 Oct 20;27(30):5039-48. doi: 10.1200/JCO.2008.20.5450. Epub 2009 Sep 14. J Clin Oncol. 2009. PMID: 19752343 Free PMC article.
14,860 results
You have reached the last available page of results. Please see the User Guide for more information.